Early Life
Mustafa Hamied, born in Mumbai, India, is the son of Khwaja Abdul Hamied, the founder of Cipla. His father, a disciple of Mahatma Gandhi, instilled in him the values of self-sufficiency and accessible healthcare. After completing his education, Hamied joined Cipla, contributing to the company's early growth.
Rise to Success
After his father's passing in 1972, Mustafa Hamied and his brother Yusuf Hamied inherited the business. Mustafa, a science graduate, played a pivotal role in Cipla's expansion. The company became a major player in the pharmaceutical industry, offering a wide range of generic and branded medicines. Hamied's career at Cipla spanned 47 years. He resigned as Vice Chairman and Non-Executive Director in October 2024 due to age and health.
Key Business Strategies
Cipla, under the Hamied family, focused on producing affordable generic drugs, particularly for diseases prevalent in developing countries. The company's strategy included a focus on respiratory disease medication. Cipla expanded its manufacturing facilities and distribution networks globally, establishing a strong presence in India, South Africa, the US, and other emerging markets. Key decisions, such as launching Deferiprone, the world's first oral iron chelator, in 1995, highlighted the company's innovative approach.
Philanthropy
Mustafa Hamied, through Cipla, has been involved in numerous initiatives aimed at making healthcare accessible. Cipla has been certified as a water-positive organization, marking a significant milestone in its sustainability journey, and has supported education and research through the Cipla Foundation. Cipla's impact has been shaped by its commitment to affordable healthcare solutions.
